Bertrand Georges
Chief Technology Officer
molecular and cel immunology
Immune Targeting Systems Ltd
United States of America
Biography
Dr. Georges has 15 years expertise in the field of molecular & cellular immunology and T cell vaccine development. He was co-founder and Chief Technology Officer of Immune Targeting Systems (ITS) Limited from 2004 until its acquisition by us in March 2015. Prior to ITS, Dr. Georges held the position of head of immunology at SEDAC-Therapeutics from 1999 until 2003. Dr. Georges has significant experience in product formulation and manufacturing, preclinical and early clinical development with a focus on peptide-based vaccines.
Research Interest
Dr. Georges has a special interest in designing vaccines against infectious diseases and cancer and has developed T cell epitope identification methodologies combining in silico, in vitro and in vivo approaches. He received his Ph.D. in Molecular Immunology from the Pasteur Institute and is the co-author of 18 publications and co-inventor of 11 patent families.
